OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
Anjan Selz is CEO and co-founder of Finox Biotech
Key business considerations when developing biosimilar products virtually.
How does working in a virtual biotech environment affect biosimilar development? Anjan Selz outlines target and partner selection in this first of a two part article.
Virtual biotech CEO Anjan Selz focuses on product development, credibility and differentiation.